pain treatment FDA approved device

Product Specification

Product Description

The Almag-01 uses Traveling Pulsed Electromagnetic Fields (tPEMF) to help relieve pain and inflammation, among other uses. AlmagThe Almag-01 is ISO and CE approved as a tPEMF device, and is FDA listed as a biofeedback device. Due to the nature and distribution of the magnetic field, the Almag-01 can impact a large area at one time. It comes with detailed instructions and doesn't require special training. Check out these videos for a more visual demonstration. The Almag-01 has been used to counter the effects of sedentary lifestyles, non-manual work and long periods sitting with a computer. Patients have used it to improve visual acuity, and for osteochondrosis, headaches, muscle flaccidity, neurasthenia, hemorrhoids and some prostate conditions, among others. What is tPEMF? Traveling Pulsed Electromagnetic Field therapy involves impulses similar to the biological frequencies of your body. As it travels, it can enhance bioactive properties along the organs and body. The dynamics do not allow for adaptation, so the body does not get used to it. This allows the beneficial effects to remain constant. Similar devices have been used for years to treat fractures, injuries and post operative wounds, but many of those devices were large and cumbersome. This device is small, making it perfect for clinics or for home use. Using tPEMF, an analgesic effect is created due to blockage of nerve impulses, reducing spasms and improving local circulation and tissue respiration. This can lead to improved immune responses. PEMF devices were approved by the FDA in 1979 for the stimulation of bone growth. It was approved in the US in 1991 as an adjunct for treatment of post-operative edema and pain. It was again approved by the FDA in 2004 for patients with a high risk for non-fusion, as an adjunct to cervical fusion surgery. It's a proven safe therapy for fractures and a variety of other problems. How does the Almag-01 work? The Almag-01 can cause an increase in intercellular and intracellular exchange due to the interaction of charged particles. The magnetic field increases interactions between redox process chemical elements, helping to improve tissue and cell metabolism and enhancing the ionization process. Studies show the Almag-01 penetrates deeper than other devices, enough to influence internal organs. Frequencies are within 4-16Hz, the most biologically active. Numerous studies in Europe, Russia, Australia and India show the effectiveness of this device. It is used to help relieve pain and restore mobility, returning the patient to a more active life TABLE OF CONTENTS: 1. Purpose of the Device 1.1 General information 1.2 Indications for application. 1.3 Contraindications 2. Specifications 3. Delivery complete set 4. Principle of device operation 4.1 Physiological effect of traveling pulsed magnetic field on human organism 4.2 Arrangement of the Device 4.3 Marking 5. Safety measures 6. Preparation for use 7. Therapeutic procedure Locomotors system diseases – Osteochondrosis – Deforming osteoarthrosis Arthritis and arthrosis of different joints – Scapulohumeral periarthritis – Arthritis – Epicondylitis – Gout – Bursitis – Myositis – Paratenonitis Locomotors system injuries – Bone fractures – Internal joint injuries – Wounds, soft tissues bruise, hematoma, post traumatic oedema – Ligament and muscle injuries – Post-operation wounds – Keloid cicatrix – Sluggish purulent wounds, phlegmons, burns Diseases of peripheral nervous system – Neuritis – Facial nerve neuritis – Radial nerve neuritis – Ulnar nerve neuritis – Median nerve neuritis – Sciatic (sciatica) nerve neuritis – Perennial nerve neuritis – Plexitis – Neuralgia – Trigeminal nerve neuralgia – Occipital nerve neuralgia – Intercostal neuralgia Central nervous system traumas: – Vertebral column and spinal cord traumas – Disorder of spinal blood circulation Brain vascular diseases – Ischemic cerebral stroke Diseases of cardiovascular system – Hypertension of degree I and II – Renal hypertension – Hypertonic type of vegeto-vascular dystonia – Ischemic illness of heart with the stable tension stenocardia – obliterating atherosclerosis (endarteritis) of the vessels of the lower extremities Pancreatic diabetes complications – Diabetic angiopathy – Diabetic polyneuropathy Dermatologic diseases – Itching dermatosis – Dermal plastic operation postoperative condition Chronic nonspecific lung diseases – Chronic bronchitis – Chronic pneumonia – Bronchial asthma Gastrointestinal tract disorders – Subacute and chronic pancreatitis – Biliary dyskinesia – Chronic gastritis – Stomach and duodenum ulcer Female genital organs diseases Uterus and uterine appendages inflammatory diseases in the subacute period – Diseases caused by ovary hypo function – Cesarean post operation condition Diseases of venous system of the upper and lower extremities – Deep vein thrombosis of a lower leg Chronic thrombophlebitis in a stage of trophic disorders varicose illness *** ALMAG-01 is made to be used for treatment and prophylactic of a wide spectrum of diseases using the tPEMF (Traveling Pulsed Magnetic Field Therapy). While using this devise, as recommended by your physician or therapist, follow the suggested therapeutic regime. This operating manual is a document guaranteeing the basic parameters of ALMAG-01, and certifying its technical characteristics. Also, this manual is a guide to show the purchaser all the methods and techniques of using this devise. 1. PURPOSE OF THE DEVICE 1.2 INDICATIONS FOR USE Locomotors system diseases: – Spinal osteochondrosis with reflex cervical spine, thorax and loin radicular syndrome – Deforming osteoarthrosis – Arthritis and arthrosis of different joints: scapulohumeral periarthritis, arthritis, epicondylitis, gout – Bursitis – Myositis – Paratenonitis Locomotors system juries and their after-affect: – Bone fractures; – Internal joint damages; – Posttraumatic joint contracture; – Wound- soft tissue bruise, hematoma, and posttraumatic edema; – Muscle and ligaments injuries; -postoperative wounds; – Keloid cicatrix; – Sluggish purulent wounds, phlegmons, burns. Neurologic diseases: – Diseases of peripheral nervous system; – Neuritis’s: – Facial nerve neuritis – Radial nerve neuritis – Neuritis of the ulnar nerve – Median nerve neuritis – Sciatic nerve (ischias) neuritis – Peroneal nerve neuritis – Plexitis – Neuralgias: – Trigeminal nerve neuralgia, – Occipital nerve neuralgia, – Intercostal neuralgia Traumas of central nervous system: – Trauma of a backbone and a spinal cord; – Disorder of a spinal blood circulation, – Circulation with chronic ischemic illness of heart Brain vascular diseases: – Ischemic cerebral stroke. Diseases of cardiovascular system: – Idiopathic hypertension of I – II degree; – Renal hypertonic; – Vegetovascular dystonia about the hypertonic type; – Ischemic illness of heart with a stable stenocardia (under the medial supervision); – obliterating atherosclerosis of vessels of the lower extremities (obliteration endarteritis). Complications of diabetes: – Diabetic angiopathy; – Diabetic polyneuropathy. Dermatologic diseases: -itching dermatosis; -Dermal plastic operation postoperative condition. Chronic nonspecific lung diseases: – Chronic bronchitis; – Chronic pneumonia; – Bronchial asthma. Gastrointestinal tract disorders: – Subacute and chronic pancreatic; – Biliary dyskinesia; – Chronic gastritis – Stomach and duodenum ulcer; Female genital organs diseases – Uterus and uterine appendages inflammatory diseases in the subacute period – Diseases caused by ovary hypo function – Cesarean post operation condition Venous disorders of upper and lower extremities: – Thrombosis of deep chin veins; – Chronic thrombophlebitis at the trophic disturbance stage; – Varicose disease 1.3. CONTRAINDICATIONS – Inflammably diseases in the acute phase; Hemorrhage and predisposition to it; High-grade hypotension; Purulent processes before surgical treatment; Severe cardiac ischemia; Early post infarction period; Acute phase of cerebral blood circulation disturbance (stroke); Pregnancy; Systemic blood diseases; Oncological diseases; Thyrotoxicosis; Diencephalic syndrome; The presence of implanted cardio stimulator in the zone of action. The presence of small metal inclusions in the osseous tissue does not serve the contraindication to the use of device in the therapeutic doses.